Schrödinger is abandoning its CDC7 inhibitor after the therapy was linked to the deaths of two patients in a phase 1 leukemia trial. The biotech had been evaluating the asset, dubbed SGR-2921, in an ...
Acute leukemia arises from genetic alterations within hematopoietic cells, which lead to unregulated cellular proliferation. Scientists have detected rearrangements of the lysine methyltransferase 2A ...
SHENZHEN, China, Sept. 9, 2025 /PRNewswire/ -- XtalPi Inc. (Stock Code: 2228.HK) has announced that PEP08, a next-generation PRMT5 inhibitor candidate developed through its AI drug discovery ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback